Patents by Inventor Michael TIMANER

Michael TIMANER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260151432
    Abstract: The invention relates to an activating composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent. Further, there is provided an activating composition comprising a supernatant of a composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent and wherein the supernatant is used as a therapy. The invention further provides methods for treating or preventing a disease or a condition comprising the use of the activated composition.
    Type: Application
    Filed: January 21, 2026
    Publication date: June 4, 2026
    Inventors: Yuval SHAKED, Michael TIMANER
  • Patent number: 12558376
    Abstract: The invention relates to an activating composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent. Further, there is provided an activating composition comprising a supernatant of a composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent and wherein the supernatant is used as a therapy. The invention further provides methods for treating or preventing a disease or a condition comprising the use of the activated composition.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: February 24, 2026
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Yuval Shaked, Michael Timaner
  • Publication number: 20230158078
    Abstract: Methods of treating, ameliorating or preventing an acute respiratory disease or condition or cytokine storm in a subject in need thereof, comprising administering to the subject a pharmaceutical composition comprising an effective amount of MSCs contacted with chemotherapy or conditioned media from the MSCs contacted with chemotherapy are provided.
    Type: Application
    Filed: January 9, 2023
    Publication date: May 25, 2023
    Inventors: Yuval SHAKED, Michael TIMANER
  • Publication number: 20210338737
    Abstract: The invention relates to an activating composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent. Further, there is provided an activating composition comprising a supernatant of a composition comprising a cell, which may be any cell type used for cell therapy, wherein the cell is activated by a chemotherapy agent and wherein the supernatant is used as a therapy. The invention further provides methods for treating or preventing a disease or a condition comprising the use of the activated composition.
    Type: Application
    Filed: August 29, 2019
    Publication date: November 4, 2021
    Inventors: Yuval SHAKED, Michael TIMANER